305 related articles for article (PubMed ID: 32208163)
1. Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease.
Zhang M; Yuan Y; Zhou W; Qin Y; Xu K; Men J; Lin M
Comput Biol Chem; 2020 Jun; 86():107248. PubMed ID: 32208163
[TBL] [Abstract][Full Text] [Related]
2. A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors.
Nie H; Deng Y; Zheng C; Pan M; Xie J; Zhang Y; Yang Q
J Cell Mol Med; 2020 May; 24(9):5168-5184. PubMed ID: 32189432
[TBL] [Abstract][Full Text] [Related]
3. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.
Gao SS; Sun JJ; Wang X; Hu YY; Feng Q; Gou XJ
Biomed Res Int; 2020; 2020():1704960. PubMed ID: 33204683
[TBL] [Abstract][Full Text] [Related]
4. The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.
Zhang M; Yuan Y; Wang Q; Li X; Men J; Lin M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30291215
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of Alisma orientale in treating nonalcoholic fatty liver disease].
Jiang-Dong D; Chuan-Yan L; Bing Y; Yue W; Li C; Liang F; Xiao-Bin J
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4140-4148. PubMed ID: 33164398
[TBL] [Abstract][Full Text] [Related]
6. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
[TBL] [Abstract][Full Text] [Related]
7. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
Li S; Wu X; Ma Y; Zhang H; Chen W
J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
PeerJ; 2022; 10():e14171. PubMed ID: 36389420
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment.
Sun CY; Yang LL; Zhao P; Yan PZ; Li J; Zhao DS
Hereditas; 2022 Dec; 159(1):44. PubMed ID: 36451177
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Ganshuang granules on non-alcoholic fatty liver and underlying mechanism: a network pharmacology and experimental verification.
Guoguo Z; Bingjie S; Tianyan Z; Shaoxiu JI; Jingwei LI; Yanni D; Feng L; Dong W
J Tradit Chin Med; 2024 Feb; 44(1):122-130. PubMed ID: 38213247
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of Ginkgo biloba in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease based on network pharmacology, molecular docking, and experimental evaluations.
Xu S; Tang L; Qian X; Wang Y; Gong J; Yang H; Su D
J Food Biochem; 2022 Dec; 46(12):e14419. PubMed ID: 36121703
[TBL] [Abstract][Full Text] [Related]
12.
Peng C; Li J; Ke X; Liu F; Huang KE
Ann Med; 2023 Dec; 55(1):2200258. PubMed ID: 37096878
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effect and Mechanism Prediction of Fuzi-Gancao Herb Couple on Non-alcoholic Fatty Liver Disease (NAFLD) based on Network Pharmacology and Molecular Docking.
Liu K; Yang X; Zhang G; Xiang Z
Comb Chem High Throughput Screen; 2024; 27(5):773-785. PubMed ID: 37317908
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of Shouhui Tongbian Capsules in treating constipation based on network pharmacology and molecular docking].
Liang HB; Li R; Yao JC; Qin GF; Zhang H; Zhang GM
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):511-519. PubMed ID: 33645014
[TBL] [Abstract][Full Text] [Related]
15. Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology.
Yu C; Han D; Yu J; Zhu R; Zhu C; Wang F; Zhang T
Medicine (Baltimore); 2023 Oct; 102(42):e35460. PubMed ID: 37861538
[TBL] [Abstract][Full Text] [Related]
16. Investigation on the mechanism of Ginkgo Folium in the treatment of Non-alcoholic Fatty Liver Disease by strategy of network pharmacology and molecular docking.
Sun Y; Wang L; Du L; Yu H; Tian Y; Jin H; Li S; Yan S; Xiao X
Technol Health Care; 2023; 31(S1):209-221. PubMed ID: 37038793
[TBL] [Abstract][Full Text] [Related]
17. Network Pharmacology Exploration Reveals Anti-Apoptosis as a Common Therapeutic Mechanism for Non-Alcoholic Fatty Liver Disease Treated with Blueberry Leaf Polyphenols.
Wang CR; Chen HW; Li Y; Zhou MY; Wong VK; Jiang ZH; Zhang W
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836315
[TBL] [Abstract][Full Text] [Related]
18. Systematic Evaluation of the Mechanisms of Mulberry Leaf (Morus alba Linne) Acting on Diabetes Based on Network Pharmacology and Molecular Docking.
Wu Q; Hu Y
Comb Chem High Throughput Screen; 2021; 24(5):668-682. PubMed ID: 32928080
[TBL] [Abstract][Full Text] [Related]
19. [Study on hepatoprotective mechanisms of Veratrilla baillonii based on network pharmacology].
He CJ; Wang J; Liang S; Li J; Huang XJ
Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1789-1799. PubMed ID: 32489062
[TBL] [Abstract][Full Text] [Related]
20. The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study.
Oh KK; Yoon SJ; Lee SB; Lee SY; Gupta H; Ganesan R; Sharma SP; Won SM; Jeong JJ; Kim DJ; Suk KT
J Transl Med; 2023 Apr; 21(1):263. PubMed ID: 37069607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
